Plain-English translation of NCT07506395 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our PTSD research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage research study testing —a naturally occurring compound—combined with group-based therapy to help people with post-traumatic stress disorder (PTSD). Researchers want to see if this treatment is safe and whether it can reduce PTSD symptoms. The study is being led by the University of New Mexico and is currently looking for participants.
Current treatments for PTSD don't work well enough for everyone, and some people don't respond to traditional therapy or medications. This study explores whether combining the medication with professional therapeutic support in a group setting might offer a new path to healing for people struggling with trauma.
You likely qualify if…
You likely don't qualify if…
You would participate in a group-based therapy program where you receive the medication alongside professional therapeutic support. The study involves preparation sessions before taking the medication, the actual treatment session, and follow-up sessions afterward. All visits are being carefully monitored by medical professionals to watch for any side effects or safety concerns. The study will track changes in your PTSD symptoms over time using standard questionnaires and clinical assessments.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States